Shana Godfred-Cato, Clarisse A Tsang, Jennifer Giovanni, Joseph Abrams, Matthew E Oster, Ellen H Lee, Maura K Lash, Chloe Le Marchand, Caterina Y Liu, Caitlin N Newhouse, Gillian Richardson, Meghan T Murray, Sarah Lim, Thomas E Haupt, Amanda Hartley, Lynn E Sosa, Kompan Ngamsnga, Ali Garcia, Deblina Datta, Ermias D Belay
BACKGROUND: Multisystem inflammatory syndrome in children (MIS-C), temporally associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been identified in infants <12 months old. Clinical characteristics and follow-up data of MIS-C in infants have not been well described. We sought to describe the clinical course, laboratory findings, therapeutics and outcomes among infants diagnosed with MIS-C. METHODS: Infants of age <12 months with MIS-C were identified by reports to the CDC's MIS-C national surveillance system...
July 1, 2021: Pediatric Infectious Disease Journal